Ionis Pharmaceuticals News

Express News | Ionis Pharmaceuticals Inc - Donidalorsen Pdufa Date Set for August 21, 2025

BreakingsNov 4 22:45

Express News | Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of Hae

BreakingsNov 4 22:45

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

PR NewswireNov 4 22:44

Earnings Preview: IONS to Report Financial Results on November 06

$Ionis Pharmaceuticals(IONS.US)$ is scheduled to release its financial results on November 06 ET. Earnings PreviewAnalysts estimate $Ionis Pharmaceuticals(IONS.US)$ to post revenue of USD129.68M for 2

Futu NewsNov 1 09:00

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500

BenzingaNov 1 03:23

Ionis Pharmaceuticals' (NASDAQ:IONS) Investors Will Be Pleased With Their 30% Return Over the Last Three Years

Yahoo FinanceOct 23 23:48

Ionis to Hold Third Quarter 2024 Financial Results Webcast

PR NewswireOct 23 19:05

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT NewswiresOct 21 21:15

TD Cowen Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $59

Futu NewsOct 21 19:31 · Ratings

Ionis Pharmaceuticals (IONS) Receives a Buy From TD Cowen

TipRanksOct 21 18:54 · Ratings

Ionis Pharmaceuticals Reports WAINZUA Recommended for Approval in the EU by CHMP

InvestingOct 21 18:00

Ionis And AstraZeneca's WAINZUA Recommended For EU Approval As First Self-Administered Treatment For HATTR-PN

BenzingaOct 21 14:53

Express News | Wainzua (Eplontersen) Recommended for Approval in the EU by Chmp for the Treatment of Adults With Polyneuropathy Associated With Hereditary Transthyretin-Mediated Amyloidosis

BreakingsOct 21 14:08

Morgan Stanley Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $55

Futu NewsOct 11 20:31 · Ratings

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Ionis Pharmaceuticals (IONS) and Amicus (FOLD)

TipRanksOct 11 20:30 · Ratings

Wolfe's Tax Loss Selling Stocks Within Communications, Discretionary, Staples, Energy, Financials, Health Care

Seeking AlphaOct 11 02:37

Guggenheim Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Raises Target Price to $65

Futu NewsOct 9 19:35 · Ratings

Express News | Ionis Pharmaceuticals Inc : Guggenheim Cuts Target Price to $65 From $70

BreakingsOct 9 18:26

Laidlaw Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $68

Futu NewsOct 9 08:31 · Ratings

Biogen Says Higher Dose of Nusinersen Shows Clinical Benefits in Spinal Muscular Atrophy

MT NewswiresOct 8 20:53